KERYX BIOPHARMACEUTICALS INC Inventory Write-down
KERYX BIOPHARMACEUTICALS INC reported Inventory Write-down of $1.80 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2018-11-08
- KERYX BIOPHARMACEUTICALS INC inventory write-down for the quarter ending 2018-09-30 was $1.80M, a 63.64% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for the quarter ending 2018-06-30 was $1.20M, a 300.00% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for the quarter ending 2018-03-31 was $4.10M, a 1720.89% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for the quarter ending 2017-12-31 was $1.80M, a 84.54% decline year-over-year.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for fiscal 2017 was $3.47M, a 87.60% decline from fiscal 2016.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for fiscal 2016 was $27.97M.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for fiscal 2015 was $0.00.
- KERYX BIOPHARMACEUTICALS INC inventory write-down for fiscal 2014 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2018-09-30 | $1.80M 10-Q · filed 2018-11-08 | $3.00M derived: sum of 2 quarters · filed 2018-11-08 | $7.08M 10-Q · filed 2018-11-08 | $8.89M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $1.20M 10-Q · filed 2018-08-09 | $5.29M 10-Q · filed 2018-08-09 | $7.09M derived: sum of 3 quarters · filed 2018-08-09 | $8.19M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $4.10M 10-Q · filed 2018-05-10 | $5.89M derived: sum of 2 quarters · filed 2018-05-10 | $6.99M derived: sum of 3 quarters · filed 2018-11-08 | $7.29M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.90M derived: sum of 2 quarters · filed 2018-11-08 | $3.20M derived: sum of 3 quarters · filed 2018-11-08 | $3.47M 10-K · filed 2018-02-21 |
| 2017-09-30 | $1.10M 10-Q · filed 2018-11-08 | $1.40M derived: sum of 2 quarters · filed 2018-11-08 | $1.67M 10-Q · filed 2018-11-08 | $13.24M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-09 | $335.00K 10-Q · filed 2018-08-09 | $12.14M derived: sum of 3 quarters · filed 2018-08-09 | $25.76M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $225.00K 10-Q · filed 2018-05-10 | $11.84M derived: sum of 2 quarters · filed 2018-05-10 | $25.46M derived: sum of 3 quarters · filed 2018-05-10 | $28.19M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $11.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $25.23M derived: sum of 2 quarters · filed 2018-02-21 | $27.97M derived: sum of 3 quarters · filed 2018-02-21 | $27.97M 10-K · filed 2018-02-21 |
| 2016-09-30 | $13.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $16.35M derived: sum of 2 quarters · filed 2017-11-07 | $16.35M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $2.74M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-21 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |